Alterations of immune response of non-small cell lung cancer with Azacytidine

Innovative therapies are needed for advanced Non-Small Cell Lung Cancer (NSCLC). We have undertaken a genomics based, hypothesis driving, approach to query an emerging potential that epigenetic therapy may sensitize to immune checkpoint therapy targeting PD-L1/PD-1 interaction. NSCLC cell lines were...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Wrangle, John, Wang, Wei, Koch, Alexander, Easwaran, Hariharan, Mohammad, Helai P., Vendetti, Frank, VanCriekinge, Wim, DeMeyer, Tim, Du, Zhengzong, Parsana, Princy, Rodgers, Kristen, Yen, Ray-Whay, Zahnow, Cynthia A., Taube, Janis M., Brahmer, Julie R., Tykodi, Scott S., Easton, Keith, Carvajal, Richard D., Jones, Peter A., Laird, Peter W., Weisenberger, Daniel J., Tsai, Salina, Juergens, Rosalyn A., Topalian, Suzanne L., Rudin, Charles M., Brock, Malcolm V., Pardoll, Drew, Baylin, Stephen B.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2013
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3875770/
https://ncbi.nlm.nih.gov/pubmed/24162015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados